Latest Regulatory Clearance News

Evergreen Lithium has secured key regulatory approvals to begin reverse circulation drilling at its Mt Monger Gold Project, targeting high-potential gold prospects Duchess of York and Kiaki Soaks. The campaign aims to unlock valuable insights and guide further exploration in 2026.

Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.

United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.

Imricor Medical Systems has completed the world’s first Pulsed Field Ablation procedure under real-time MRI guidance, marking a breakthrough in cardiac ablation technology. This pre-clinical success validates their Vision-MR platform’s adaptability and sets the stage for safer, radiation-free heart treatments.

Tivan Limited has received regulatory clearance to begin drilling at its Sandover Fluorite Project, aiming to unlock high-grade fluorite deposits with assays reaching 94% CaF2. The staged drilling program marks a significant step toward defining a commercially viable resource.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Liberty Metals has secured an option to acquire three strategically located critical mineral projects in Brazil, targeting high-purity rutile and rare earth elements. This move positions the company in a Tier 1 mining jurisdiction with promising exploration upside.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Infomedia Limited has received crucial regulatory clearance from the German Federal Ministry for Economic Affairs and Energy for its proposed acquisition by McQueen BidCo, advancing the scheme of arrangement. The company’s board continues to recommend shareholder approval amid remaining conditions.

MAC Copper Limited’s shares will be suspended from trading following court approval of its acquisition by Harmony Gold, marking a significant shift in ownership for the copper miner.